
LabGenius Therapeutics
AI-driven drug discovery platform for rapid development of novel therapeutics.
About
LabGenius Therapeutics is an AI-driven drug discovery company that leverages its proprietary platform to accelerate the development of novel therapeutics. Their approach combines advanced machine learning with high-throughput experimentation to identify and optimize drug candidates more efficiently than traditional methods.
Listed competitors
Also in this space
Leveraging the adaptive immune system to diagnose and treat disease.
Shares Biotech, HealthTech
Cradle Bio B.V. is a Dutch, Swiss biotechnology company that develops software using machine learning for protein engineering. It was founded in 2021 and is base
Shares Biotech, HealthTech
Computational protein design company creating novel enzymes and proteins using AI and physics-based modeling.
Shares Biotech, AI-Driven Protein Design
Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.
Shares Biotech, HealthTech
AI-powered drug discovery and development platform for biologics.
Shares Biotech, Drug Discovery
AI platform for drug discovery and development, accelerating research with advanced computational tools.
Shares Biotech, Drug Discovery
Key facts
- Website
- labgeniustx.com
- Headquarters
- London, United Kingdom
- Founded
- 2019
- Total funding
- $3M (Seed)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 1 Jan 2019 | Seed | $3M |
Tech stack
Detected on labgeniustx.com, last scanned 13 Nov 2026. Run your own scan
- Compliance
- GDPR, CCPA
- Frontend
- jQuery
- Analytics
- Google Analytics 4
- SEO
- All in One SEO
- CMS / Builders
- WordPress
- Hiring platform
- Teamtailor
Test your Ahrefs DR
The backlink strength of a domain, on the Ahrefs 0 to 100 scale. About a minute.
Frequently asked
Is LabGenius Therapeutics trustworthy and reputable?
StartupHub's Data Trust & Reputation score for LabGenius Therapeutics is 83 out of 100, a trusted rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has LabGenius Therapeutics raised?
LabGenius Therapeutics has raised a total of $3M in funding. The most recent round on record is Seed.
SEC filings, insider activity, nonprofit links and pay benchmarks for LabGenius Therapeutics:
Company details: from public sources. Funding: no announced round on file. Ownership: not yet claimed by the company. Scores: measured by named tools; each links to its method. Our rules


